The next phase of distribution for the COVID-19 vaccine in Ohio will begin this week and include increased eligibility, according to an announcement from Ohio Gov. Mike DeWine on Monday.Read More
A single dose of Pfizer’s coronavirus vaccine may offer sufficient protection against the virus for people who have already had COVID-19, two studies show.
“This could potentially accelerate vaccine rollout,” researchers at University College of London and Public Health England said in the first study. “With increasing variants, wider coverage without compromising vaccine-induced immunity could help reduce variant emergence.”Read More
Johnson & Johnson’s one-dose vaccine is effective in preventing severe and fatal coronavirus cases, and may reduce the virus’s transmission among vaccinated people, the FDA said in new analyses Wednesday.
The drug maker announced in January that its vaccine was 72% effective against the virus in the United States and 64% effective in South Africa, where a mutated, more transmissible strain has become dominant. Its vaccine was 86% effective in preventing severe virus cases in the U.S., meaning that a vaccinated individual is at a far smaller risk of being hospitalized or dying from COVID-19.Read More
The state of Ohio has published a list of medical conditions that qualify residents to receive the coronavirus vaccination in the most recent phase of eligibility.Read More
Ohio Gov. Mike DeWine said on Tuesday that the next group of Ohioans to be eligible for the coronavirus vaccine will under the age of 65, although he did not say exactly who will be included in the next phase.Read More
Johnson & Johnson filed for emergency use authorization from the FDA on Thursday for its coronavirus vaccine.
The drug maker’s application followed its announcement that its vaccine was 72% effective in combating the virus. Although that’s slightly lower than Pfizer and Moderna’s vaccines, Johnson & Johnson’s requires one dose instead of two.Read More
Johnson & Johnson announced on Friday that its coronavirus vaccine was 72% effective in combating COVID-19, but only 57% effective against a novel South African strain.
While slightly less effective than Pfizer and Moderna’s vaccines, which were both approved by the FDA in December, Johnson & Johnson’s vaccines provides significant distribution advantages that could be crucial in the nation’s fight against the virus. Unlike Pfizer and Moderna, Pfizer’s vaccine is just one shot, and can be stored in refrigerators instead of freezers.Read More
The Ohio Department of Health has published a list of school districts whose staff will be eligible to receive the coronavirus vaccine starting next week.Read More
Hospitals have come under sharp criticism for their part in the chaotic COVID-19 vaccine rollout. That’s because in the rush to get the vaccine out quickly, many hospitals were shipped more vaccine than anticipated and fewer staff took it than anticipated. As a result, hospitals accrued a vaccine surplus and offered it to their low-risk grad students and young administrative staff working from home and are now scrambling to figure out what to do with the rest. The answer should be simple: give it to older members of your community, but a recent letter from the American Hospital Association cited a number of important barriers to effective vaccine distribution including a lack of coordination and guidance from federal, state, and local governments.Read More
Nearly all of Ohio’s schools have committed to returning to some form of in-person learning by March 1, Ohio Gov. Mike DeWine said on Tuesday.Read More
Ohio residents ages 80-years-old and older will be eligible to receive a coronavirus vaccination starting on Tuesday, January 19 as Phase 1B of the Ohio Department of Health’s COVID-19 Vaccination Program begins.Read More
Trader Joe’s is the latest business offering financial incentives to encourage their workers to get the COVID-19 vaccine.
The grocery chain said Thursday it will give employees two hours of pay per dose for getting the vaccine. The Monrovia, California based company said it will also shift around schedules to make sure employees have time to get vaccinated, according USA Today.Read More
The Trump administration is expected to alter its coronavirus vaccine distribution guidance, recommending that people aged 65 and older are made eligible to be inoculated, The New York Times reported.
The Department of Health and Human Services (HHS) and Department of Defense are expected to announce the new guidance at a noon press conference, an anonymous official briefed on the announcement told the Times. The change to the recommendations is intended to quicken the distribution of the coronavirus vaccine, which has been far behind pace.Read More
The proper conservative response to last Wednesday’s violent entry into the Capitol and vandalism, as well as assaults on law-enforcement, is to identify the guilty parties and ensure they are arrested.
Such deterrence will prevent any future devolution from legal popular protests into thuggery. No constitutional republic can tolerate its iconic heart stormed, breached, and defiled.Read More
The vaccine developed by Pfizer and BioNTech protects against a highly contagious strain of coronavirus that originated in South Africa and the U.K., according to a study published Thursday.
The study, which was commissioned by Pfizer, is likely to alleviate some fears that the virus variant would evade protections offered by the vaccine.Read More
More than 70 percent of COVID-19 vaccines have gone unused, still sitting in freezers US health officials said on Monday.
In Daytona Beach, hundreds of senior citizens camped out in their vehicles in chilly overnight temperatures in the low 40s to secure a place in a vaccination line Tuesday morning, a day after seniors jammed the roads to the vaccination site, NBC Miami reported.Read More
Ohio Gov. Mike DeWine announced on Tuesday that the next phase of coronavirus vaccinations should begin in two weeks.Read More
Over 9 million COVID-19 vaccines have yet to be administered in the U.S. since they were initially distributed on Dec. 13, according to the Centers for Disease Control and Prevention.
Of the 12,409,050 doses of the vaccines that have been distributed, only 2,794,588 have been administered as of Wednesday morning, according to the Centers for Disease Control and Prevention (CDC).Read More
Ohio Gov. Mike DeWine and the Ohio Department of Health announced the second phase of vaccine distribution last week, with those over the age of 65 and those living with medical issues to be next in line to receive the vaccine.Read More
Ohio Gov. Mike DeWine plans to offer vaccines to all schools in the state that want it by mid-January in an effort to get children back to in-person learning in districts that want to return.
At his regular news conference Wednesday, DeWine announced new phases of vaccine distribution that included adults in school districts, those 64 years old and older, along with those with severe medical conditions.Read More
More than a million Americans have received the first round of vaccinations for the coronavirus as of Wednesday at 9 a.m., the Centers for Disease Control and Prevention (CDC) announced.
Over nine million coronavirus doses have been distributed and 1,008,025 doses have been administered, according to the CDC’s COVID Data Tracker.Read More
The CEO of BioNTech, the German drug maker who partnered with Pfizer in developing the world’s first approved coronavirus vaccine, said that he was “confident” it will be effective against a mutated strain of the virus found in the United Kingdom.
“The likelihood that our vaccine works… is relatively high,” Uğur Şahin told reporters during a Tuesday press conference, explaining that the mutated strain still shares approximately 99% of the original strain’s spike protein.Read More
Democratic Speaker of the House Nancy Pelosi said Monday that “faith-oriented” people in Congress have told her they “don’t believe in science.”
The California Democrat spoke Monday on the house floor where she discussed coronavirus relief and the recently approved vaccines, accusing the White House of spreading “quackery” notions of herd immunity.Read More
The two coronavirus vaccines that have been approved for emergency use authorization in the U.S. will be able to combat a new, more contagious strain of the virus in the U.K., experts said Monday.
Vaccines made by pharmaceutical companies Pfizer and Moderna will be effective against the new strain, which is “very similar” to previous strains at the genetic level, University of Washington’s Institute for Health Metrics and Evaluation affiliate assistant professor Vin Gupta told CNBC. The Food and Drug Administration has approved both vaccines for emergency use authorization after large-scale human trials showed efficacy of more than 90%.Read More
The FDA approved Moderna’s coronavirus vaccine for emergency use Friday, making the United States the first country to have approved two safe and effective vaccines against COVID-19.
Its approval follows a key FDA panel’s overwhelming vote Thursday to endorse the vaccine’s safety and efficacy. The Moderna vaccine’s approval means that its distribution could begin within hours, providing hospitals and long-term care facilities across the country thousands of much-needed doses.Read More
Ohio began administering the coronavirus vaccine in its nursing homes for the first time on Friday as part of a federal program that pairs pharmacies with long-term care facilities.Read More
Pfizer CEO Albert Bourla said on CNN Monday that the U.S. is seeking to double its COVID-19 vaccine order.
“So far, we have an agreement with the U.S. Government to provide them 100 million doses and this is a fixed order and we will provide those 100 million doses starting from now by the end of the first quarter and we will honor this commitment,” Bourla told CNN Chief Medical Correspondent Dr. Sanjay Gupta on “New Day With Alisyn Camerota and John Berman.”Read More
Video footage showed the first shipment of the coronavirus vaccine leaving Pfizer’s Michigan location on Sunday.
UPS, Boyle and FedEx trucks were captured on video leaving the facility located close to Kalamazoo, Michigan.Read More
The Ohio Department of Health has released its vaccine distribution plan, even as the state waits for final approval from the U.S. Food and Drug Administration for a vaccine.Read More
Pharmaceutical company Moderna announced Monday that it will submit its coronavirus vaccine to the federal government for emergency use authorization approval.
Moderna said it would ask the Food and Drug Administration (FDA) for approval after its large-scale human trial concluded and showed the company’s vaccine to have an overall efficacy of 94.1%, according to NBC News. The vaccine was found to be 100% effective in preventing severe cases of coronavirus, according to Moderna.Read More
Ohio should start to see the first batch of COVID-19 vaccines by mid-December, according to an announcement from Ohio Gov. Mike DeWine on Tuesday.
DeWine said during a press conference on Tuesday that the vaccine will be delivered to Ohio around December 15.Read More
More Americans said that they would receive a coronavirus vaccine when available than they did a month ago, according to a new Gallup poll released Tuesday.
Fifty-eight percent of Americans indicated their willingness to take a vaccine in the poll, which surveyed Americans in late October. That number is up eight percent from Gallup’s previous September poll.Read More
While Democrats including presidential candidate and former Vice President Joe Biden, vice presidential candidate Sen. Kamala Harris (Calif.), House Speaker Nancy Pelosi (Calif.), Senate Minority Leader Chuck Schumer (N.Y.), Gov. Andrew Cuomo (N.Y.), Gov. Gavin Newsom (Calif.), Gov. Ned Lamont (Conn.), and Chicago Mayor Lori Lightfoot all publicly question the Trump administration’s ability to facilitate a safe COVID-19 vaccine, could arsonist-turned-firefighter China have the cure we all need?Read More
Department of Health and Human Services Sec. Alex Azar said Wednesday that he expects a coronavirus vaccine to be available for vulnerable Americans by January 2021.
The Health and Human Services (HHS) secretary said that vaccines will be immediately be offered to seniors, health care workers and first responders once hospitals are able to administer it, according to The Hill. Sec. Alex Azar’s comments came at press briefing at the Centers for Disease Control and Prevention headquarters.Read More
A Trump administration official leading the response to the coronavirus pandemic says the U.S. can expect delivery of a vaccine starting in January 2021, despite statements from the president that inoculations could begin this month.
And a growing, bipartisan chorus of lawmakers, experts and public health officials says the country is ill prepared for a projected winter surge of COVID-19.Read More
Russia on Tuesday became the first country to approve a coronavirus vaccine, a move that was met with international skepticism and unease because the shots have only been studied in dozens of people.
President Vladimir Putin announced the Health Ministry’s approval and said one of his two adult daughters already was inoculated. He said the vaccine underwent the necessary tests and was shown to provide lasting immunity to the coronavirus, although Russian authorities have offered no proof to back up claims of safety or effectiveness.Read More
Researchers, governments and pharmaceutical companies worldwide have been working rapidly to develop an effective vaccine against coronavirus, which has infected over 4.5 million and killed over 150,000 people in the United States alone.
Testing has advanced quickly and there’s optimism that a vaccine will be developed before 2021. But there are also concerns that a vaccine won’t be sufficiently stockpiled or efficiently distributed. There’s additional worry that the growing distrust in vaccines will result in large numbers refusing the injection, making it less beneficial.Read More
Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of an experimental COVID-19 vaccine to the United States as governments buy up supplies in hopes of securing a candidate that works.
The United States will pay up to $2.1 billion “for development including clinical trials, manufacturing, scale-up and delivery” of the vaccine, the two companies based in Europe said in a statement. Sanofi will get the bulk of the funds.Read More
Dr. Carl Sagan was one of the premier scientists when it came to trying to bridge the gap of hard science with general public understanding. In the process, his personal enthusiasm for the wonder of science became evident to all. He also understood that science could be hijacked and that the highest standards of evidence were required when fantastic claims were being made.Read More
by Jason Hopkins White House National Security Adviser Robert O’Brien on Sunday suggested that the Chinese Community Party would very likely try to steal American developments on a coronavirus vaccine. During an appearance on CBS’s “Face the Nation,” O’Brien predicted that the United States would be the first country…Read More
There are only two ways human action can get the SARS-CoV-2 virus permanently behind us and return to normal life: we either develop a knock-out therapy that kills the virus dead in people who have contracted it, like powerful antibiotics do with bacterial infections, or we need to develop herd immunity. Without one of those, we are left hoping that the virus simply burns itself out and disappears. That would be foolish. But a knockout drug—a cure—is highly unlikely. There is no such drug for the seasonal flu or for the rhinoviruses that cause the common cold. So while effective therapies should be a part of the strategy to combat the ill effects of this virus, and sensible precautions like masks can prevent its spread, the only way to permanently defeat it is through herd immunity.Read More
Tuberculosis (TB) is a vicious epidemic that is drastically underfunded. That was the takeaway message from the first high-level meeting focused on the infectious disease at the U.N. General Assembly in New York. Amina Mohammad, U.N. deputy secretary-general, said the disease is fueled by poverty, inequality, migration and conflict, and…Read More